"With two large campuses in Berlin, New Jersey, and Marlton, New Jersey, (both just twenty minutes from Philadelphia), Hassman Research Institute (HRI) is a leading clinical research organization that conducts studies in a wide variety of therapeutic areas. HRI’s highly trained and experienced staff, including four board certified clinical investigators, is dedicated to maintaining the highest standard of quality results in the trials they conduct. On the HRI campus there are fourteen private practices led by physicians that serve as sub-investigators."

During the past decade, CNS Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CNS Research Institute" #1 sponsor was "Cephalon" with 7 trials, followed by "Forest Laboratories" with 2 trials sponsored, "Sunovion" with 2 trials sponsored, "Celtic Pharma Development Services" with 1 trials sponsored and "Corcept Therapeutics" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "CNS Research Institute" are "Major Depressive Disorder" (3 trials), "Schizophrenia" (3 trials), "ADHD" (1 trials), "Anxiety Disorders" (1 trials) and "Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "CNS Research Institute" in a lesser frequency.

Most popular intervention types in "CNS Research Institute" are "Drug" (14 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Escitalopram" (2 trials), "Gabitril" (2 trials), "Modafinil" (2 trials) and "Armodafinil" (1 trials). Other intervention names were less common.

The vast majority of trials in "CNS Research Institute" are 15 trials for "All" genders.

Currently, there are NaN active trials in "CNS Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in CNS Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CNS Research Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".